Back to search
FDAFDA · Food and drugs·Recall number D-0760-2026

TADALAFIL USP, 0.100 KG, 0.1KG(100gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesania, Gujarat, 382715, India, (CAS NO 1715996-29-5), NDC 85702-002-02.

Published August 19, 2026 · Recall initiated: August 3, 2026

Summary

FDA records drug Class II recall D-0760-2026, published August 19, 2026 and initiated August 3, 2026. Recalling firm: Shoolin Pharma Chem LLP; Status: Ongoing; Reported quantity: 1KG - 100-0.1KG(100gm) bags; Lot: Lot: TLF2506001, Date of Expiry: May 31, 2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations:Noted during FDA inspection

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Shoolin Pharma Chem LLP
Distributor
Distributed Nationwide in the USA
Lot
Lot: TLF2506001, Date of Expiry: May 31, 2028.
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was TADALAFIL USP, 0.100 KG, 0.1KG(100gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesania, Gujarat, 382715, India, (CAS NO 1715996-29-5), NDC 85702-002-02. recalled?

Yes. FDA published recall D-0760-2026 on August 19, 2026. Reported hazard: CGMP Deviations:Noted during FDA inspection

What should I do if I have this product?

Voluntary: Firm initiated